Differentiating Human Induced Pluripotent Stem Cells (iPSCs) Into Lung Epithelial Cells

Area of Science:

• Stem cell biology
• Developmental biology
• Regenerative medicine

Background:

• Human induced pluripotent stem cells (hiPSCs) hold promise for developmental studies and clinical cell-based therapies.
• Understanding human lung development is crucial for addressing respiratory diseases.
• Existing methods for generating lung epithelial cells from hiPSCs require optimization for clinical applications.

Purpose of the Study:

• To develop a protocol for differentiating hiPSCs into lung epithelial cell types that mimics in vivo development.
• To establish a robust method for generating patient-derived lung cells for disease modeling and drug screening.
• To validate the protocol using hiPSCs produced under current Good Manufacturing Practice (cGMP) conditions.

Main Methods:

• Initiation of differentiation from hiPSCs towards a definitive endoderm fate.
• Progression of cells into anteriorized foregut endoderm.
• Induction of proximal and distal lung epithelial cell differentiation.

Main Results:

• The protocol successfully recapitulates the stepwise differentiation events observed during in vivo lung development.
• Generated lung epithelial cells possess the potential to differentiate into both proximal and distal cell types.
• The differentiation protocol was successfully reproduced using cGMP-grade hiPSCs, indicating clinical translatability.

Conclusions:

• This protocol provides a reliable method for generating diverse lung epithelial cell types from hiPSCs.
• The methodology facilitates disease modeling, pharmacological screening, and the development of personalized cell therapies for lung conditions.
• cGMP-compliant hiPSC differentiation is a critical step towards the clinical application of these cells in regenerative medicine.